MMRF: Multiple Myeloma Genomic Initiative

Recognizing that new genomic technologies now present unprecedented opportunities in advancing myeloma research and drug discovery, we are especially proud to lauch the Multiple Myeloma Genomic Initiative.

This flagship genomic mapping program--a multi-million dollar undertaking--will enable researchers to determine what genes and proteins play a role in the disease's onset and progression, to learn how specific patients respond to therapies, and to identify new druggable targets for the disease. Unique and novel, this pioneering research effort will accelerate the pace of myeloma discovery.

Source: MMRF mailing